Condition
Colorectal Liver Metastases clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Colorectal Liver Metastases clinical trials that are recruiting, at sites in 6 countries (most in China (3), Italy (1), France (1)). By phase: Phase 1 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Colorectal Liver Metastases clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery | — | Hefei, Anhui | Recruiting | Sep 21, 2026 |
| Liver transplant vs removal of liver tumors after conversion therapy for initially unresectable colorectal liver metastases | — | Milan | Recruiting | May 26, 2026 |
| Paclitaxel liver-artery infusion plus standard chemo for first-line colorectal liver metastases | Phase 1 | Lishui, Zhejiang | Recruiting | Aug 12, 2025 |
| Combining ivonescimab with chemotherapy for treating colorectal cancer liver metastases | Phase 2 | Beijing | Recruiting | Feb 27, 2025 |
| Adjuvant FOLFIRI after surgery for colorectal liver metastases that responded to preoperative FOLFIRI | Phase 3 | Paris, Île-de-France Region | Recruiting | Jul 15, 2024 |
| Microwave ablation for colorectal liver metastases | — | Miami, Florida and 6 other locations | Recruiting | Mar 3, 2022 |
All recruiting trials (6)
-
Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery
Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.
-
Liver transplant vs removal of liver tumors after conversion therapy for initially unresectable colorectal liver metastases
This trial tests whether liver transplantation or liver surgery with ablation best helps people whose colorectal liver metastases were initially unresectable but became potentially resectable after conversion therapy.
-
Paclitaxel liver-artery infusion plus standard chemo for first-line colorectal liver metastases
This trial will see if giving paclitaxel cationic liposome into the liver artery together with standard first-line chemotherapy (oxaliplatin and capecitabine, with or without bevacizumab) helps people with inoperable colorectal liver metastases.
-
Combining ivonescimab with chemotherapy for treating colorectal cancer liver metastases
This study is testing if adding ivonescimab to chemotherapy can help people with colorectal cancer that has spread to the liver feel better and improve their treatment results.
-
Adjuvant FOLFIRI after surgery for colorectal liver metastases that responded to preoperative FOLFIRI
This trial tests whether giving FOLFIRI chemotherapy after liver surgery helps people whose colorectal liver metastases responded to preoperative FOLFIRI and who could not receive oxaliplatin.
-
Microwave ablation for colorectal liver metastases
This study is testing if microwave ablation can effectively treat small colorectal liver tumors in people and help them live without cancer progression for at least two years.
Related topics
Quick answers
How many Colorectal Liver Metastases clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (3 trials), Italy (1 trial), France (1 trial), Greece (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.